The purpose of this study is to learn how people with BRCA1/2 mutations respond to genetic risk modifier testing. The researchers will learn more about how people make choices about their health care, including about methods to screen for prostate cancer. Researchers are also doing this study to learn about how the genetic risk modifier test affects people's thoughts and feelings.
Study Type
OBSERVATIONAL
Enrollment
150
swab sample in person or at home with a mailed test kit and will fill out a survey
about 1 week, 6 months, and 12 months after getting the updated cancer risk assessment to complete additional surveys.
for research testing
Memorial Sloan Kettering Cancer Center
New York, New York, United States
RECRUITINGIntention to undergo prostate cancer screening options
Change in intention for each screening option measured with the Choice predisposition scale. Choice Predisposition scale ranges from 1 (leaning towards yes) to 15 (leaning towards no) regarding a specific option.
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.